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A B ST R AC T  
            
Aim: To investigate the effects of cordycepin on the histopathological changes and oxidative stress 
induced by hepatic ischemia/reperfusion (I/R) in rats. 
Method: Forty male Wistar rats were randomly divided into 4 groups as group I (sham, n=10), group 
II (control, n=10), group III (I/R-untreated, n=10) and group IV (I/R-cordycepin, n=10). Liver 
ischemia was induced for 30 min then reperfusion was allowed for 1 h. At the end of the experiment, 
liver specimens and blood samples were taken for histopathological and antioxidant evaluations, and 
biochemical analysis. 
Results: The levels of IL6, IL-1β, and TNFα in the serum and liver tissues were higher in the I/R-
untreated group compared to the I/R-cordycepin treated group. In the I/R-cordycepin group, serum 
MDA levels were decreased compared with the I/R-untreated group. The I/R-cordycepin treated 
group showed an increase in TAS levels, and a decrease in TOS levels compared with I/R-untreated 
group. The histopathological injury score were significantly lower in the I/R-cordycepin treated group 
compared to the I/R-untreated group.  In the I/R-untreated group, the integrity of the hepatocyte cell 
lines deteriorated. Mononuclear inflammatory cells infiltrated the parenchyma regions, the sinuses 
dilated and there was diffuse congestion Preoperative treatment with cordycepine reduced 
histopathological abnormalities. 
Conclusion: Cordycepin has demonstrated significant hepatoprotective effects against I/R injury 
induced in rats through TAS elevation and reduction of TOS, MDA and proinflammatory cytokines. 
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Introduction 
Liver ischemia-reperfusion (I/R) is an 
important pathophysiological condition 
encountered in such conditions as trauma, 
shock, and transplantation [1]. Despite the 
widespread knowledge in the literature on 
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biochemical and metabolic changes in liver I/R 
injury, studies in animal models demonstrating 
cellular and ultrastructural changes often 
involve in the process [2,3]. Liver I/R damage 
involves multifactorial complex mechanisms, 
and reactive oxygen species (ROS) production 
is one of them which can lead to cell damage 
and death [4]. Oxidation of intracellular 
organelles, such as proteins, lipids and DNA, 
plays a role in both damage to the intracellular 
organelles and in cell death. In addition, 
mitochondria are a major producer of both 
reactive oxygen species (ROS) and primary 
oxidative stress target organ [5,6]. 
Furthermore, the release of other pro-
inflammatory cytokines such as (TNF-α), 
interleukin (IL)-1β and interleukin-6 (IL-6) 
may result in increased inflammatory status 
and activation in Kupffer cells [7-9]. 
Cordycepin (3-deoxyadenosine), a functional 
component of Cordyceps militaris, has a wide 
biological field with antitumor, anti-
inflammatory, antidiabetic and antioxidant 
properties [10-12]. Recent studies have 
suggested that cordycepin prevents cellular 
damage caused by I/R, reducing oxidative 
damage and increasing free radical scavenging 
activity [13,14]. In the current literature, we 
did not find a study that showed the effect of 
cordycepin on liver ischemia-reperfusion 
injury. Then, our aim in this experimental 
study is to investigate the potential effects and 
possible mechanisms of cordycepin on liver 
ischemia-reperfusion injury in the rat model. 
 
Material and methods 
Animals 
Forty male Wistar rats (250–300 g) obtained 
from Dicle University Dr. Sabahattin Payzin 
Health Sciences Application and Research 
Center were used for this experimental study. 
The experimental procedures were approved 
by the Animal Ethics Committee of Dicle 
University (DUHADEK) and animals were 
handled following the International Animal 
Ethics Guidelines. Animals were kept in their 
personal cages under a 12/12 hour light / dark 
cycle, with free access to tap water and food. 
Room temperature and humidity were carried 
out at 23±1 °C and 55±5%, respectively. 
 
Liver ischemia reperfusion model 
All rats were anesthetized with 
Ketamine/Xylazine (Ketalar, Parke-Davis, 
Istanbul, Turkey 100 mg/ kg, Rompun®; 
Bayer AG, Leverkusen, Germany 10 mg/kg, 
respectively). For liver I/R [15], after midline 
laparotomy, pedicle composed the portal vein, 
the hepatic artery, and the bile duct were 
clamped with an artery clip. During ischemia, 
normal saline was injected into the abdominal 
cavity at 37 °C every 10 minutes and the clips 
were removed after 30 minutes. Reperfusion 
was applied for 30 minutes. During this time, 
the body was kept on a hot plate set at 37 °C to 
maintain heat.  
 
Study protocol 
Animals were divided into four experimental 
groups (n=10) as follows: Group I (Sham): 
Dissection of hepatoduodenal ligament was 
performed and no medication was given. 
Group II (Control): In addition to dissection, 
cordyceptin (Product NumberC3394; Sigma, 
St. Louis, MO, USA) was given at a dose of 10 
mg/kg by oral lavage 15 min before the 
experimental study. Group III (I/R-untreated): 
Thirty minutes after the Pringle maneuver, 
reperfusion was performed for 30 min and no 
drug was given. Group IV (I/R-cordyceptin 
treated): In addition to procedures of Group 3, 
cordyceptin was given at a dose of 10 mg/kg 
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by oral lavage 15 min before the ischemia 
period. 
Blood and tissues of liver lobes from sham-
control and I/R injury animals were collected.  
The liver tissues were then divided into two 
parts: one part was kept in 10% formalin for 
histopathological evaluation and the other part 
was immediately ﬂash frozen in liquid nitrogen 
and kept at − 80 °C for measurement of tissue 
parameters.  
 
Determination of oxidative stress markers 
and inﬂammatory cytokines 
Serum TAS and TOS were measured using 
commercial kits (Rel Assay Diagnostics, 
Gaziantep, Turkey) and an Abbott Architect 
C16000 auto analyzer (Abbott Diagnostic 
Laboratories, Chicago, IL, USA) using the 
automated colorimetric measurement methods 
developed by Erel et al. [16]. The TAS results 
are presented as the micromolar 
troloxequivalent per liter (μm Troloxequiv. / 
L). The TOS results are presented as the micro 
molar hydrogen peroxide equivalent per liter 
(μmol H2O2 Equiv./L). The MDA content was 
evaluated spectrophotometrically, as described 
previously [17], using a method based on the 
spectrophotometric measurement of the color 
that develops during a reaction between 
thiobarbituric acid and MDA.  
The serum levels of TNF-α, IL-1β, and IL-6 
were evaluated using enzyme-linked 
immunosorbent assays (ELISAs) according to 
the manufacturer’s instructions. The data 
obtained from tissue biochemistry experiments 
were entered in to a form that was prepared in 
advance. Tissue particles weighing 0.12–0.24 
g were irrigated with physiological saline, 
dried using blotting paper, placed into 
Eppendorf tubes, and stored at −85°C until use. 
Once all of the sampling procedures were 
complete, the tissues were homogenized using 
an automated tissue homogenizer after 
thawing. Then, TNF-α, IL-6, IL-1β, TAS, 
TOS, and MDA levels were evaluated in the 
liver tissues. 
 
Histopathological examination 
Paraﬃn tissue blocks were all set for 
sectioning at 4 µm' thickness. The obtained 
tissue sections were set on glass slides, 
deparaﬃnized, stained by Hematoxylin and 
Eosin (H&E). The hepatic histological damage 
scale consists of 4 grades (G0–G3): grade 0 
indicates normal histological structure; grade 1 
indicates mild injury with cytoplasm 
vacuolization and focal nuclear pyknosis; 
grade 2 indicates moderate-to-severe injury 
with extensive nuclear pyknosis, loss of 
intercellular borders, and mild-to-moderate 
neutrophil inﬁltration; grade 3 indicates severe 
injury with disintegration of hepatic cords, 
hemorrhage, and severe polymorphnuclear 
neutrophil (PMN) inﬁltration [18].  
 
Statistical analysis 
Differences for the biochemical and 
histopathologic results between the groups 
were assessed using Kruskal-Wallis and 
Mann-Whitney U tests. P values <0.05 were 
considered to indicate statistical significance. 
 
Results 
A results of the biochemical and 
histopathological parameters is presented in 
Table 1. Biochemical analyses revealed that 
the levels of IL6, IL-1β, and TNFα in the 
serum and liver tissues were higher in the I/R-
untreated group compared to the I/R-
cordycepin treated group (p<0.05, p<0.05 and 
p<0.05, respectively). In the I/R- cordycepin 
group, serum MDA levels were decreased 
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compared with the I/R-untreated group (p < 
0.05). But there was no difference between the 
two groups in terms of tissue MDA levels.  The 
I/R-cordycepin treated group showed increase 
 
Table 1. Blood, tissue biochemical parameters and Liver Injury Score of the all groups. 
  
Parameters 
Group I 
(Sham) 
Group II 
(Control) 
Group III 
(I/R-untreated) 
Group IV 
(I/R- Cordycepin) 
Blood  
    IL-1β (pg/L) 
    IL-6 (pg/ml) 
    TNF-α (ng/L) 
    MDA (µM) 
    TAS (μm Trolox- equiv./L) 
    TOS (μm H2O2 equiv./L) 
 
651±90 
38±5 
18 ±10 
12,3±1,05 
1± 0,1 
407±160 
  
652±79 
38±5 
21±2,5 
17,3±2,1 
1±0,5 
579±40 
  
3661±408*▲ 
304±17*▲ 
78±11*▲ 
24±3,4 
1,6±0,4*▲ 
2784±424*▲ 
  
2142±143*▲† 
317±20*▲  
31±8*▲† 
15,6±1,9† 
2,3±0,1*▲† 
765±34 
Tissue 
    IL-1β (pg/ g protein) 
    IL-6 (pg/ g protein) 
    TNF-α (ng/ g protein) 
    MDA (µM/g protein) 
    TAS (μmTroloxequiv./g                
protein) 
     TOS (μm H2O2 equiv/ g protein) 
  
122±26 
32±17 
52±27 
14,9±2,4 
0,6±0,1 
  
3084±1210 
  
  
151±33 
41±9 
62±11 
18,3±2,5 
0,8±0,1 
  
2860±885 
  
  
755±180*▲ 
186±30*▲ 
92±10*▲ 
27,4±3,3*▲ 
0,4±0,2* 
  
10307±2810*▲ 
  
  
212±95† 
75±17*▲† 
73±7 
23±4,4 
0,8±0,1† 
  
4911±1041*▲† 
  
  
Liver injury score 
  
0,4±0,1 
  
  
05±0,1 
  
  
2,18±0,1*▲ 
  
  
1,3±0,4*▲† 
I/R: Ischemia reperfusion; TNF-α: Tumor necrosis factor-alpha; IL-1β: Interleukin-1 beta; IL-6: Interleukin 6; 
MDA: Malondialdehyde TOS: Total oxidative stress, TAS: Total antioxidant status.*Group I vs. groups III 
and IV. ▲Group II vs. groups III and IV. † Group IV vs. group III.  
 
 
  
Fig. 1A-C.  A) In sham-control group, the structures of hepatocytes and portal areas were observed to be of 
normal appearance (H&E, x100). B) In the I/R-untreated control group, disruption in the integrity of hepatocyte 
mononuclear inflammatory cells, sinusoidal dilatation, diffuse congestion and hepatocyte vacuolization were 
showed (H&E, x100). C) In the liver parenchyma of cordycepin group animals, rare mononuclear 
inflammatory cells and mild sinusoidal congestion were observed (H&E, x100).
20 
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in TAS levels and decrease in TOS levels,  
compared with I/R-untreated group. 
The mean histopathological scores of the 
groups are given in Table 1. The 
histopathological injury score were 
significantly lower in the I/R-cordycepin 
treated group compared to the I/R-untreated 
group (p<0.05). The histopathological findings 
are presented in Figures 1 to 3.  Liver tissue 
sections from the sham-control group were 
found in normal morphology [Fig. 1A]. In the 
I/R-untreated group, the integrity of the 
hepatocyte cell lines deteriorated. 
Mononuclear inflammatory cells infiltrated the 
parenchyma regions, the sinuses dilated and 
there was diffuse congestion [Fig. 1B]. 
Preoperative treatment with cordycepine 
reduced histopathological abnormalities 
compared to the I / R- untreated group [Fig. 
1C]. 
 
Discussion 
ROS plays an important role in I/R 
mechanisms. ROS, which occurs in increased 
parameters such as superoxide anion, 
hydrogen peroxide, hydroxyl radical, and lipid 
peroxides, occurs in the reperfusion phase 
following tissue ischemia and causes tissue 
damage. Tissue MDA is the best predictor of a 
structural oxidative injury in the cell 
membrane [19-21]. Cordyceps sinensis is a 
caterpillar fungus, and their bioactive agent is 
called cordycepin (3′-deoxyadenosine). It is a 
natural derivative of the nucleoside adenosine 
with only one absence of oxygen in the 3′ 
position of the ribose part [22,23]. The effects 
of cordycepin on cell biology related to ROS 
have been reported. For this reason, the anti-
tumor, anti-inflammatory, antiangiogenic and 
anti-oxidant effects of cordycepin have been 
extensively investigated in various 
experimental models [24-27]. Cordycepin also 
acts on specific cell types by decreasing 
oxidative stress [28]. Dou et al. [14] further 
suggested that cordycepin treatments 
scavenged the generation of ROS, upregulated 
interferon regulatory factor 8 (IRF-8) and 
suppressed the activity of nuclear factor of 
activated T cells c1 (NFATc1) during 
osteoclastogenesis. On the other hand, the anti-
tumor effect of cordycepin has been shown to 
be mediated through ROS-induced apoptosis 
[27]. Cordycepin has also been reported to 
stimulate cAMP and cGMP production in 
platelets [28]. In another study, the production 
of ROS, O2- and H2O2, induced by platelet-
derived growth factor-BB was abolished by the 
treatment of cordycepin [29]. In their study, 
Jeong et al. investigated the apoptotic effects 
of cordycepin in human leukemia cells, and 
treatment with cordycepin significantly 
inhibited cell growth in a concentration-
dependent manner by inducing apoptosis but 
not necrosis. They suggested that this 
induction was associated with generation of 
ROS, mitochondrial dysfunction, activation of 
caspases, and cleavage of poly (ADP-ribose) 
polymerase protein [27]. Xiao et all. [25] 
demonstrated that cordycepin could ameliorate 
albumin-induced epithelial-mesenchymal 
transition of renal tubular cells by decreasing 
NADPH oxidase activity and inhibiting ROS 
production.  After I/R, it was found to be an 
increase in inflammatory mediators such as 
TNF-a, IL-6 and IL-1β. The release of these 
proinflammatory cytokines causes aggravation 
in inflammation. They also have a stimulatory 
effect on neutrophils [30,31].  
In the current study, there was an increase in 
pro-inflammatory cytokine levels after I/R. 
TNF-α, IL-1, and IL-6 levels were decreased 
in response to the anti-inflammatory effects of 
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cordycepin. We believe that these effects are 
associated with the anti-inflammatory effects 
of the drug. Additionally, we observed a 
significant increase in TAS in the cordycepin 
versus I/R-untreated group and was also a 
significant decrease in the TOS level. In the 
present study, we showed that the activity of 
MDA increased in the hepatic tissue after I/R-
induced injury. Conversely, cordycepine 
treatment decreased MDA levels. 
 
Conclusion 
For the first time, cordycepin has demonstrated 
significant hepatoprotective effects against I/R 
injury induced in rats through TAS elevation 
and reduction of TOS, MDA and 
proinflammatory cytokines. Treatment with 
cordycepine in patients with liver I / R injury 
in different clinical situations may be a 
promising strategy. However, newer and more 
extensive experimental studies may be 
indicative 
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